BACKGROUND: Beta-catenin has been historically recognized as both an intermediate in the "canonical Wnt signaling pathway" and as a component of functional adherens junctions. MATERIALS AND METHODS: Cellular accumulation of beta-catenin levels can result in transactivation of gene transcription and cellular proliferation during normal cellular and disease development. Recent evidence has identified beta-catenin in an additional role as a component of cutaneous wound healing. RESULTS: This finding is in keeping with previous observations that post-translational modifications of beta-catenin that are associated with its cytoplasmic accumulation are frequently observed in fibroproliferative diseases with characteristics of dysregulated wound healing. These diseases include hypertrophic scar formation, aggressive fibromatoses, Lederhose disease, and Dupuytren's contracture (DC). CONCLUSIONS: While its precise roles in disease initiation and progression remain to be explored, this review highlights our current knowledge of beta-catenin regulation and describes some potential upstream mediators of beta-catenin accumulation and signaling in fibroproliferative disease.
BACKGROUND:Beta-catenin has been historically recognized as both an intermediate in the "canonical Wnt signaling pathway" and as a component of functional adherens junctions. MATERIALS AND METHODS: Cellular accumulation of beta-catenin levels can result in transactivation of gene transcription and cellular proliferation during normal cellular and disease development. Recent evidence has identified beta-catenin in an additional role as a component of cutaneous wound healing. RESULTS: This finding is in keeping with previous observations that post-translational modifications of beta-catenin that are associated with its cytoplasmic accumulation are frequently observed in fibroproliferative diseases with characteristics of dysregulated wound healing. These diseases include hypertrophic scar formation, aggressive fibromatoses, Lederhose disease, and Dupuytren's contracture (DC). CONCLUSIONS: While its precise roles in disease initiation and progression remain to be explored, this review highlights our current knowledge of beta-catenin regulation and describes some potential upstream mediators of beta-catenin accumulation and signaling in fibroproliferative disease.
Authors: Justin M M Cates; Jennifer O Black; Doha M Itani; John H Fasig; Vicki L Keedy; Kenneth R Hande; Brent W Whited; Kelly C Homlar; Jennifer L Halpern; Ginger E Holt; Herbert S Schwartz; Cheryl M Coffin Journal: Hum Pathol Date: 2012-04-18 Impact factor: 3.466
Authors: Thu H Tran; Andrew Jarrell; Gabriel E Zentner; Adrienne Welsh; Isaac Brownell; Peter C Scacheri; Radhika Atit Journal: Development Date: 2010-10-27 Impact factor: 6.868
Authors: Khosrow S Houschyar; Arash Momeni; Malcolm N Pyles; Zeshaan N Maan; Alexander J Whittam; Frank Siemers Journal: Organogenesis Date: 2015 Impact factor: 2.500
Authors: Fu-Lun Li; Hui Deng; Hong-Wei Wang; Rong Xu; Jie Chen; Yi-Fei Wang; Xin Li; Bin Fan; Bin Li Journal: Chin J Integr Med Date: 2011-04-21 Impact factor: 1.978
Authors: Linda Vi; Anna Njarlangattil; Yan Wu; Bing Siang Gan; David B O'Gorman Journal: BMC Musculoskelet Disord Date: 2009-06-19 Impact factor: 2.362